Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers

BACKGROUND: Hormone therapy (HT) is commonly given to women to alleviate the climacteric symptoms associated with menopause. There is concern that this treatment may increase the risk of breast cancer. The potential association of HT and breast cancer risk is of particular interest to women who carr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Eisen, Andrea, Lubinski, Jan, Gronwald, Jacek, Moller, Pal, Lynch, Henry T., Klijn, Jan, Kim-Sing, Charmaine, Neuhausen, Susan L., Gilbert, Lucy, Ghadirian, Parviz, Manoukian, Siranoush, Rennert, Gad, Friedman, Eitan, Isaacs, Claudine, Rosen, Eliot, Rosen, Barry, Daly, Mary, Sun, Ping, Narod, Steven A.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2008
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2556701/
https://ncbi.nlm.nih.gov/pubmed/18812548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn313
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars